Malvern, PA-based Solstice Neurosciences has garnered $85 million in debt and equity financing in its second round. Highland Capital Management of Dallas, Texas, led the round with existing investors Thomas, McNerney & Partners, Investor Growth Capital, Morgan Stanley Venture Partners, and Oxford Bioscience Partners.
- see the release on the new round